JWBC
MRNA icon

John W. Brooker & Co’s Moderna MRNA Stock Holding History

John W. Brooker & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-150
Closed -$18K – 136
2022
Q3 		$18K Hold
150
– – 0.01% 122
2022
Q2 		$21K Hold
150
– – 0.01% 115
2022
Q1 		$26K Hold
150
– – 0.01% 111
2021
Q4 		$38K Hold
150
– – 0.02% 100
2021
Q3 		$58K Buy
150
+100
+200% +$36.9K 0.03% 76
2021
Q2 		$12K Sell
50
-70
-58% -$12.5K 0.01% 130
2021
Q1 		$16K Buy
120
+70
+140% +$10.1K 0.01% 109
2020
Q4 		$5K Hold
50
– – ﹤0.01% 144
2020
Q3 		$4K Buy
+50
New +$3.49K ﹤0.01% 145

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

John W. Brooker & Co's MRNA Position: Q4 2022 in Review

John W. Brooker & Co sold out of Moderna (MRNA) in Q4 2022, closing a stake of 150 shares — an estimated $18K sold.

John W. Brooker & Co first reported a position in MRNA in Q3 2020 and held it in 9 quarters. The position peaked at $58K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • John W. Brooker & Co reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • John W. Brooker & Co sold 150 Moderna shares in Q4 2022, an estimated $18K.
  • John W. Brooker & Co first reported a position in Moderna in Q3 2020 and held it in 9 quarters.
  • John W. Brooker & Co's Moderna position peaked at $58K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on John W. Brooker & Co's 13F filing for Q4 2022, filed 13 Jan 2023.